(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 5.53% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23%.
Zimmer Biomet Holdings's revenue in 2026 is $8,011,000,000.On average, 31 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,728,737,704,265, with the lowest ZBH revenue forecast at $1,619,539,667,460, and the highest ZBH revenue forecast at $1,820,892,127,340. On average, 24 Wall Street analysts forecast ZBH's revenue for 2027 to be $1,802,064,879,615, with the lowest ZBH revenue forecast at $1,669,679,600,875, and the highest ZBH revenue forecast at $1,915,622,910,630.
In 2028, ZBH is forecast to generate $1,859,339,349,010 in revenue, with the lowest revenue forecast at $1,722,792,257,615 and the highest revenue forecast at $1,999,057,345,285.